JPWO2022046815A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022046815A5 JPWO2022046815A5 JP2023513298A JP2023513298A JPWO2022046815A5 JP WO2022046815 A5 JPWO2022046815 A5 JP WO2022046815A5 JP 2023513298 A JP2023513298 A JP 2023513298A JP 2023513298 A JP2023513298 A JP 2023513298A JP WO2022046815 A5 JPWO2022046815 A5 JP WO2022046815A5
- Authority
- JP
- Japan
- Prior art keywords
- aav
- vector
- sequence
- aav vector
- fusion protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063069500P | 2020-08-24 | 2020-08-24 | |
| US63/069,500 | 2020-08-24 | ||
| PCT/US2021/047411 WO2022046815A1 (en) | 2020-08-24 | 2021-08-24 | Viral vectors encoding glp-1 receptor agonist fusions and uses thereof in treating metabolic diseases |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023543125A JP2023543125A (ja) | 2023-10-13 |
| JPWO2022046815A5 true JPWO2022046815A5 (https=) | 2024-09-02 |
| JP2023543125A5 JP2023543125A5 (https=) | 2024-09-02 |
| JP7840319B2 JP7840319B2 (ja) | 2026-04-03 |
Family
ID=78032497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023513298A Active JP7840319B2 (ja) | 2020-08-24 | 2021-08-24 | Ｇｌｐ－１受容体アゴニスト融合物をコードするウイルスベクター及び代謝性疾患の治療におけるその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230372539A1 (https=) |
| EP (1) | EP4200429A1 (https=) |
| JP (1) | JP7840319B2 (https=) |
| CN (1) | CN116438312A (https=) |
| AU (1) | AU2021332235A1 (https=) |
| BR (1) | BR112023003310A2 (https=) |
| CA (1) | CA3190399A1 (https=) |
| MX (1) | MX2023002293A (https=) |
| WO (1) | WO2022046815A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL315256A (en) * | 2022-03-03 | 2024-10-01 | Univ Pennsylvania | AAV vectors for delivery of GLP-1 receptor agonist fusions |
| GB202403805D0 (en) * | 2024-03-15 | 2024-05-01 | Ucl Business Ltd | Compositions and methods of treatment |
| CN119351440B (zh) * | 2024-12-25 | 2025-04-25 | 浙江大学衢州研究院 | 表达glp-1的重组载体、重组酵母及应用 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| US5436146A (en) | 1989-09-07 | 1995-07-25 | The Trustees Of Princeton University | Helper-free stocks of recombinant adeno-associated virus vectors |
| US6268213B1 (en) | 1992-06-03 | 2001-07-31 | Richard Jude Samulski | Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy |
| US5478745A (en) | 1992-12-04 | 1995-12-26 | University Of Pittsburgh | Recombinant viral vector system |
| US5869305A (en) | 1992-12-04 | 1999-02-09 | The University Of Pittsburgh | Recombinant viral vector system |
| US6204059B1 (en) | 1994-06-30 | 2001-03-20 | University Of Pittsburgh | AAV capsid vehicles for molecular transfer |
| US6093570A (en) | 1995-06-07 | 2000-07-25 | The University Of North Carolina At Chapel Hill | Helper virus-free AAV production |
| US5741683A (en) | 1995-06-07 | 1998-04-21 | The Research Foundation Of State University Of New York | In vitro packaging of adeno-associated virus DNA |
| WO1998046728A1 (en) | 1997-04-14 | 1998-10-22 | Cell Genesys, Inc. | Methods for increasing the efficiency of recombinant aav product |
| WO1999061643A1 (en) | 1998-05-27 | 1999-12-02 | University Of Florida | Method of preparing recombinant adeno-associated virus compositions by using an iodixananol gradient |
| ES2340230T3 (es) | 1998-11-10 | 2010-05-31 | University Of North Carolina At Chapel Hill | Vectores viricos y sus procedimientos de preparacion y administracion. |
| PT1916258E (pt) | 1999-08-09 | 2014-07-29 | Genzyme Corp | Aumento da expressão de uma sequência nucleotídica heteróloga de cadeia simples a partir de vectores virais recombinantes por concepção da sequência de maneira que esta forme pares de bases intracadeia |
| US7201898B2 (en) | 2000-06-01 | 2007-04-10 | The University Of North Carolina At Chapel Hill | Methods and compounds for controlled release of recombinant parvovirus vectors |
| NZ532635A (en) | 2001-11-13 | 2007-05-31 | Univ Pennsylvania | A method of identifying unknown adeno-associated virus (AAV) sequences and a kit for the method |
| DK2359869T3 (en) | 2001-12-17 | 2019-04-15 | Univ Pennsylvania | Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof |
| AU2003274397A1 (en) | 2002-06-05 | 2003-12-22 | University Of Florida | Production of pseudotyped recombinant aav virions |
| MXPA05013565A (es) | 2003-06-12 | 2006-03-09 | Lilly Co Eli | Proteinas de fusion analogas al glp-1. |
| CN1856576B (zh) | 2003-09-30 | 2011-05-04 | 宾夕法尼亚州立大学托管会 | 腺伴随病毒(aav)进化支、序列、含有这些序列的载体及它们的应用 |
| WO2006110689A2 (en) | 2005-04-07 | 2006-10-19 | The Trustees Of The University Of Pennsylvania | Method of increasing the function of an aav vector |
| EP1777906A1 (en) | 2005-06-09 | 2007-04-25 | Matsushita Electric Industrial Co., Ltd. | Amplitude error compensating apparatus and orthogonality error compensating apparatus |
| US7588772B2 (en) | 2006-03-30 | 2009-09-15 | Board Of Trustees Of The Leland Stamford Junior University | AAV capsid library and AAV capsid proteins |
| US9315825B2 (en) | 2010-03-29 | 2016-04-19 | The Trustees Of The University Of Pennsylvania | Pharmacologically induced transgene ablation system |
| US20130023033A1 (en) | 2010-03-29 | 2013-01-24 | The Trustees Of The University Of Pennsylvania | Pharmacologically induced transgene ablation system |
| FR2977562B1 (fr) | 2011-07-06 | 2016-12-23 | Gaztransport Et Technigaz | Cuve etanche et thermiquement isolante integree dans une structure porteuse |
| US9719106B2 (en) | 2013-04-29 | 2017-08-01 | The Trustees Of The University Of Pennsylvania | Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof |
| CN104327187B (zh) * | 2014-10-11 | 2018-06-08 | 上海兴迪金生物技术有限公司 | 一种重组人GLP-1-Fc融合蛋白 |
| EP3332012A4 (en) * | 2015-08-06 | 2019-01-16 | The Trustees of The University of Pennsylvania | GLP-1 AND USE THEREOF IN COMPOSITIONS FOR THE TREATMENT OF METABOLISM DISEASES |
| JP7455579B2 (ja) | 2017-02-28 | 2024-03-26 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | 新規アデノ随伴ウイルス（ａａｖ）クレードｆベクター及びその用途 |
| EP4470551A3 (en) * | 2017-03-14 | 2025-02-26 | Sunshine Lake Pharma Co., Ltd. | Dual-target fusion proteins comprising the fc portion of an immunoglobulin |
| AU2019340472A1 (en) * | 2018-09-12 | 2021-04-01 | Quiapeg Pharmaceuticals Ab | Releasable GLP-1 conjugates |
| CN110964116A (zh) * | 2018-09-26 | 2020-04-07 | 北京辅仁瑞辉生物医药研究院有限公司 | GLP1-Fc融合蛋白及其缀合物 |
| WO2020184941A1 (en) * | 2019-03-08 | 2020-09-17 | Genexine, Inc. | Glp-1 fusion proteins and uses thereof |
| PE20220014A1 (es) | 2019-04-29 | 2022-01-11 | Univ Pennsylvania | Nuevas capsides de aav y composiciones que las contienen |
| WO2021081217A1 (en) * | 2019-10-23 | 2021-04-29 | The Trustees Of The University Of Pennsylvania | Compositions for drg-specific reduction of transgene expression |
-
2021
- 2021-08-24 BR BR112023003310A patent/BR112023003310A2/pt unknown
- 2021-08-24 WO PCT/US2021/047411 patent/WO2022046815A1/en not_active Ceased
- 2021-08-24 MX MX2023002293A patent/MX2023002293A/es unknown
- 2021-08-24 EP EP21783619.6A patent/EP4200429A1/en active Pending
- 2021-08-24 US US18/042,726 patent/US20230372539A1/en active Pending
- 2021-08-24 CN CN202180072447.8A patent/CN116438312A/zh active Pending
- 2021-08-24 CA CA3190399A patent/CA3190399A1/en active Pending
- 2021-08-24 AU AU2021332235A patent/AU2021332235A1/en active Pending
- 2021-08-24 JP JP2023513298A patent/JP7840319B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7522839B2 (ja) | アデノ随伴ウイルスベクターの製造プロセス | |
| JP6994018B2 (ja) | 新規アデノ随伴ウイルスキャプシドタンパク質 | |
| Tamayose et al. | A new strategy for large-scale preparation of high-titer recombinant adeno-associated virus vectors by using packaging cell lines and sulfonated cellulose column chromatography | |
| JP2024099770A5 (https=) | ||
| EP1078096A1 (en) | Multiviral compositions and uses thereof | |
| JP2022511348A (ja) | Ａａｖトリプルプラスミドシステム | |
| US20040087028A1 (en) | Ecdysone-inducible adeno-associated virus expression vectors | |
| Duan et al. | Structural and functional heterogeneity of integrated recombinant AAV genomes | |
| JP2021520837A5 (https=) | ||
| Amand et al. | Analysis of splice junctions and in vitro and in vivo translation potential of the small, abundant B19 parvovirus RNAs | |
| JP2019502378A5 (https=) | ||
| Qiu et al. | The expression strategy of goose parvovirus exhibits features of both the Dependovirus and Parvovirus genera | |
| CA2369985A1 (en) | Generation of recombinant adeno-associated viral vectors by a complete adenovirus-mediated approach | |
| Pieroni et al. | Targeted integration of adeno-associated virus-derived plasmids in transfected human cells | |
| CN115151647A (zh) | Dna扩增方法 | |
| JP2026508054A (ja) | 治療薬の生体内分布および有効性の受容体媒介制御のための標的 | |
| WO2008095027A2 (en) | Adenoviral vector comprising herpes simplex virus type 1 thymidine kinase and a transgene for increasing the expression of the transgene | |
| CA3218360A1 (en) | System for high-level raav production | |
| AU756827B2 (en) | Transcriptionally-activated AAV inverted terminal repeats (ITRs) for use with recombinant AAV vectors | |
| JPWO2022046815A5 (https=) | ||
| CA2269864A1 (fr) | Nouvelles constructions et vecteurs pour l'expression ciblee et inductible de genes | |
| JPWO2020210542A5 (https=) | ||
| JP3881382B2 (ja) | 安定にトランスフェクションされた哺乳類細胞における調節されたタンパク質発現 | |
| JPWO2023168411A5 (https=) | ||
| JPWO2023168405A5 (https=) |